LTR

阻害剤の選択性比較

カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S3998 (+)-α-Lipoic acid -1 mg/mL 41 mg/mL -1 mg/mL
S1633 Zafirlukast <1 mg/mL 100 mg/mL <1 mg/mL
S4211 Montelukast Sodium 100 mg/mL 100 mg/mL 100 mg/mL
S8126 MK571 <1 mg/mL 100 mg/mL 19 mg/mL
S5783 Montelukast <1 mg/mL 100 mg/mL 10 mg/mL
S2959 LY255283 <1 mg/mL 72 mg/mL '''<1 mg/mL

LTR製品

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S3998

(+)-α-Lipoic acid

(+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation.

S1633

Zafirlukast

Zafirlukast (ICI-204219) is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast (MK-0476) selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Precipitations may form after reconstitution,solution is best fresh-prepared.

S8126

MK571

MK571 (L660711) is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

S2959

LY255283

LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S3998

(+)-α-Lipoic acid

(+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1633

Zafirlukast

Zafirlukast (ICI-204219) is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

2020, 10(1):17659

2019, 520(1):35-40

S4211

Montelukast Sodium

Montelukast (MK-0476) selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Precipitations may form after reconstitution,solution is best fresh-prepared.

2020, 4;10(5):1585-1597

2017, 292(9):3552-3567

S8126

MK571

MK571 (L660711) is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

2020, e10852

2020, 13:1413-1419

2019, 20(24)

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

2018, 40(2):902-908

2017, 58(8):1903-1913

S2959

LY255283

LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0.